22 September 2006
Ethical and Social Aspects of Transplantation Medicine in Poland and Worldwide
Wojciech RowinskiAnn Transplant 2006; 11(3): 31-37 :: ID: 497002
Abstract
New medical technologies are products of human mind and the result of development in the field of diagnostic techniques, pharmacotherapy and biotechnology. Transplantation medicine, which is also a new medical technology, differs from the others in that it requires a living organ obtained from a dead person or a living donor. Development of market economy and globalization have made the new technologies available almost in every country. Along with them some expectations have come up among the societies, that what is possible – soon will be available. This applies also to transplantation medicine. However, its availability is restricted by flawed or misinterpreted regulations, ethical and social barriers, and financial potential. Transplantation process depends enormously on economical conditions and attitude of both the society, and the medical profession.
Keywords: Ethics, Social Barriers, economy, globalization, Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






